A Consortium consisting of 12 participants with 21 scientific groupleaders from 9 different European countries has been granted with a Sixth Framework Programme of the European Commission with the following title: “Rational Treatment Strategies Combating Mitochondrial Oxidative Phosphorylation (OXPHOS) Disorders” (EUMITOCOMBAT).
